M. L. Dalurzo Et Al. , "Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets," ONCOTARGETS AND THERAPY , vol.14, pp.4671-4692, 2021
Dalurzo, M. L. Et Al. 2021. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets. ONCOTARGETS AND THERAPY , vol.14 , 4671-4692.
Dalurzo, M. L., Aviles-Salas, A., Soares, F. A., Hou, Y., Li, Y., Stroganova, A., ... ÖZ, A. B.(2021). Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets. ONCOTARGETS AND THERAPY , vol.14, 4671-4692.
Dalurzo, Mercedes Et Al. "Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets," ONCOTARGETS AND THERAPY , vol.14, 4671-4692, 2021
Dalurzo, Mercedes L. Et Al. "Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets." ONCOTARGETS AND THERAPY , vol.14, pp.4671-4692, 2021
Dalurzo, M. L. Et Al. (2021) . "Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets." ONCOTARGETS AND THERAPY , vol.14, pp.4671-4692.
@article{article, author={Mercedes L. Dalurzo Et Al. }, title={Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets}, journal={ONCOTARGETS AND THERAPY}, year=2021, pages={4671-4692} }